Purchases and Sales Made in Q1 2023 in Inhibikase Therapeutics, Inc. (IKT)
This table provides information about the institutional ownership of Inhibikase Therapeutics, Inc. (IKT) during Q1 2023. The information is specifically focused on institutions that hold shares of Inhibikase Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
2.96MNew |
$1.6M - $2.69M
|
2.96M
$8.32M
|
|
|
May 02, 2023
Q1 2023
|
Hamilton Lane Advisors LLC
|
BUY
|
- |
82.8KNew |
$44.7K - $75.4K
|
82.8K
$233K
|
|
|
May 12, 2023
Q1 2023
|
Blair William & CO
Chicago, IL |
BUY
|
- |
47K+ 20.52% |
$25.4K - $42.8K
|
276K
$776K
|
|
|
May 09, 2023
Q1 2023
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
39KNew |
$21.1K - $35.5K
|
39K
$110K
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
15.3K+ 29.42% |
$8.26K - $13.9K
|
67.3K
$189K
|
|
|
May 01, 2023
Q1 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
13.5KNew |
$7.27K - $12.3K
|
13.5K
$37.8K
|
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.52K+ 23.29% |
$1.36K - $2.29K
|
13.3K
$37.5K
|
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1.02K+ 747.79% |
$549 - $925
|
1.15K
$3.24K
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Apr 21, 2023
Q1 2023
|
Retirement Planning CO Of New England, Inc.
Warwick, RI |
SELL
|
- |
-312- 0.89% |
$168 - $284
|
34.9K
$98.1K
|
|
|
Apr 12, 2023
Q1 2023
|
Koshinski Asset Management, Inc.
|
SELL
|
- |
-7.7K- 11.78% |
$4.16K - $7.01K
|
57.7K
$162K
|